2020 Vol.38, N°4 - Suppl.126 - Table of contents
Sjögren’s syndrome 2020
Third Annual Supplement on Sjögren’s syndrome
Guest Editors: M. Bombardieri, H. Bootsma, S. De Vita, T. Dörner, M. Ramos-Casals, A.G. Tzioufas
One year in review
CER14026
2020,38,4,Suppl.126
Pg. 0003-0009
Free to view
One year in review 2020: pathogenesis of primary Sjögren’s syndrome
M. Bombardieri, O.D. Argyropoulou, F. Ferro, R. Coleby, E. Pontarini, G. Governato, D. Lucchesi, G. Fulvio, A.G. Tzioufas, C. Baldini
M. Bombardieri, O.D. Argyropoulou, F. Ferro, R. Coleby, E. Pontarini, G. Governato, D. Lucchesi, G. Fulvio, A.G. Tzioufas, C. Baldini
CER13748
2020,38,4,Suppl.126
Pg. 0010-0022
Free to view
One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren’s syndrome
V. Manfrè, G. Cafaro, I. Riccucci, A. Zabotti, C. Perricone, H. Bootsma, S. De Vita, E. Bartoloni
V. Manfrè, G. Cafaro, I. Riccucci, A. Zabotti, C. Perricone, H. Bootsma, S. De Vita, E. Bartoloni
Editorials
CER13708
2020,38,4,Suppl.126
Pg. 0023-0024
Free to view
EULAR Sjögren’s syndrome study group: an eSSential way to address the unmet needs of the disease
A.G. Tzioufas, H. Bootsma, J.-O. Pers
A.G. Tzioufas, H. Bootsma, J.-O. Pers
CER13876
2020,38,4,Suppl.126
Pg. 0025-0026
Free to view
Sjögren’s: the patients’ perspective
K.M. Hammitt
K.M. Hammitt
Aetiopathogenesis
CER13138
2020,38,4,Suppl.126
Pg. 0027-0033
Free to view
Acinar adipose tissue infiltration in salivary gland biopsy is associated with kynurenines-interferon-γ pathway inflammation biomarkers
W.M. Sardenberg, M.C.L. Santos, K. Skarstein, L. Carvalho Caser, J.G. Brun, A. Ulvik, P.M. Ueland, P.M. Mydel, R. Jonsson, V. Valim
W.M. Sardenberg, M.C.L. Santos, K. Skarstein, L. Carvalho Caser, J.G. Brun, A. Ulvik, P.M. Ueland, P.M. Mydel, R. Jonsson, V. Valim
CER13462
2020,38,4,Suppl.126
Pg. 0034-0039
Free to view
Omega-3 and omega-6 fatty acids in primary Sjögren’s syndrome: clinical meaning and association with inflammation
C.Y. Castrejón-Morales, O. Granados-Portillo, I. Cruz-Bautista, N. Ruiz-Quintero, I. Manjarrez, G. Lima, D.F. Hernández-Ramírez, M. Astudillo-Angel, L. Llorente, G. Hernández-Molina
C.Y. Castrejón-Morales, O. Granados-Portillo, I. Cruz-Bautista, N. Ruiz-Quintero, I. Manjarrez, G. Lima, D.F. Hernández-Ramírez, M. Astudillo-Angel, L. Llorente, G. Hernández-Molina
Clinical aspects
CER12651
2020,38,4,Suppl.126
Pg. 0040-0046
Free to view
Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren’s syndrome measured using the Korean Health Insurance Claims Database
J.K. Ahn, J. Hwang, G.H. Seo
J.K. Ahn, J. Hwang, G.H. Seo
CER13116
2020,38,4,Suppl.126
Pg. 0047-0052
Free to view
Serious infections in Sjögren’s syndrome patients: a national U.S. study
J.A. Singh, J.D. Cleveland
J.A. Singh, J.D. Cleveland
CER13704
2020,38,4,Suppl.126
Pg. 0053-0056
Free to view
Significance of anti-La/SSB antibodies in primary Sjögren’s syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy
G. Cafaro, C. Perricone, C. Baldini, L. Quartuccio, R. Priori, F. Carubbi, F. Ferro, S. Colafrancesco, V. Bini, S. De Vita, R. Giacomelli, R. Gerli, E. Bartoloni
for the Italian Research Group on Sjögren’s syndrome (GRISS)
G. Cafaro, C. Perricone, C. Baldini, L. Quartuccio, R. Priori, F. Carubbi, F. Ferro, S. Colafrancesco, V. Bini, S. De Vita, R. Giacomelli, R. Gerli, E. Bartoloni
for the Italian Research Group on Sjögren’s syndrome (GRISS)
CER13711
2020,38,4,Suppl.126
Pg. 0057-0063
Free to view
Primary Sjögren's syndrome in South Australia
S.A. Lyne, S. Downie-Doyle, S.E. Lester, A. Quinlivan, P. Toby Coates, T.P. Gordon, M. Rischmueller
S.A. Lyne, S. Downie-Doyle, S.E. Lester, A. Quinlivan, P. Toby Coates, T.P. Gordon, M. Rischmueller
CER13349
2020,38,4,Suppl.126
Pg. 0064-0072
Free to view
10-year follow-up of patients with rheumatoid arthritis and secondary Sjögren’s syndrome or sicca symptoms in daily clinical practice
R.V. Moerman, S. Arends, E. Mossel, F.G. Kroese, A. Vissink, H. Bootsma
R.V. Moerman, S. Arends, E. Mossel, F.G. Kroese, A. Vissink, H. Bootsma
CER13638
2020,38,4,Suppl.126
Pg. 0073-0077
Free to view
Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjögren's syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019
H. Zhang, H. Zhang, D. Gao, Z. Zhang
H. Zhang, H. Zhang, D. Gao, Z. Zhang
CER13672
2020,38,4,Suppl.126
Pg. 0078-0084
Free to view
Comorbidity and health care utilisation in persons with Sjögren’s syndrome: a claims data analysis
K. Albrecht, T. Dörner, I. Redeker, K. Karberg, U. Marschall, A. Zink, J. Callhoff
K. Albrecht, T. Dörner, I. Redeker, K. Karberg, U. Marschall, A. Zink, J. Callhoff
CER13941
2020,38,4,Suppl.126
Pg. 0085-0094
Free to view
Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies
N. Acar-Denizli, I.-F. Horváth, T. Mandl, R. Priori, A. Vissink, G. Hernandez-Molina, B. Armagan, S. Praprotnik, A. Sebastian, E. Bartoloni, M. Rischmueller, S.G. Pasoto, G. Nordmark, H. Nakamura, V. Fernandes Moça Trevisani, S. Retamozo, S.E. Carsons, B. Maure-Noia, I. Sánchez-Berná, M. López-Dupla, E. Fonseca-Aizpuru, S. Melchor Díaz, M. Vázquez, P.E. Díaz Cuiza, B. De Miguel Campo, W.-F. Ng, A. Rasmussen, X. Dong, X. Li, C. Baldini, R. Seror, J.-E. Gottenberg, A.A. Kruize, P. Sandhya, S. Gandolfo, S.-K. Kwok, M. Kvarnstrom, R. Solans, D. Sene, Y. Suzuki, D.A. Isenberg, V. Valim, B. Hofauer, R. Giacomelli, V. Devauchelle-Pensec, F. Atzeni, T.A. Gheita, J. Morel, R. Izzo, U. Kalyoncu, A. Szántó, P. Olsson, H. Bootsma, M. Ramos-Casals, B. Kostov, P. Brito-Zerón
for the Sjögren Big Data Consortium
N. Acar-Denizli, I.-F. Horváth, T. Mandl, R. Priori, A. Vissink, G. Hernandez-Molina, B. Armagan, S. Praprotnik, A. Sebastian, E. Bartoloni, M. Rischmueller, S.G. Pasoto, G. Nordmark, H. Nakamura, V. Fernandes Moça Trevisani, S. Retamozo, S.E. Carsons, B. Maure-Noia, I. Sánchez-Berná, M. López-Dupla, E. Fonseca-Aizpuru, S. Melchor Díaz, M. Vázquez, P.E. Díaz Cuiza, B. De Miguel Campo, W.-F. Ng, A. Rasmussen, X. Dong, X. Li, C. Baldini, R. Seror, J.-E. Gottenberg, A.A. Kruize, P. Sandhya, S. Gandolfo, S.-K. Kwok, M. Kvarnstrom, R. Solans, D. Sene, Y. Suzuki, D.A. Isenberg, V. Valim, B. Hofauer, R. Giacomelli, V. Devauchelle-Pensec, F. Atzeni, T.A. Gheita, J. Morel, R. Izzo, U. Kalyoncu, A. Szántó, P. Olsson, H. Bootsma, M. Ramos-Casals, B. Kostov, P. Brito-Zerón
for the Sjögren Big Data Consortium
CER13890
2020,38,4,Suppl.126
Pg. 0095-0102
Free to view
Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases
P. Brito-Zerón, S.G. Pasoto, A. Robles-Marhuenda, T. Mandl, A. Vissink, B. Armagan, S. Praprotnik, G. Nocturne, A. Sebastian, V. Fernandes Moça Trevisani, S. Retamozo, N. Acar-Denizli, P. Wiland, A. Sisó-Almirall, H. Bootsma, X. Mariette, M. Ramos-Casals, B. Kostov
for the Sjögren Big Data Consortium
P. Brito-Zerón, S.G. Pasoto, A. Robles-Marhuenda, T. Mandl, A. Vissink, B. Armagan, S. Praprotnik, G. Nocturne, A. Sebastian, V. Fernandes Moça Trevisani, S. Retamozo, N. Acar-Denizli, P. Wiland, A. Sisó-Almirall, H. Bootsma, X. Mariette, M. Ramos-Casals, B. Kostov
for the Sjögren Big Data Consortium
CER13916
2020,38,4,Suppl.126
Pg. 0103-0109
Free to view
Primary Sjögren's syndrome: central and peripheral nervous system involvements
A. Mekinian, J. Tennenbaum, C. Lahuna, A. Dellal, N. Belfeki, J. Capron, E. Januel, B. Stankoff, S. Alamowitch, O. Fain
A. Mekinian, J. Tennenbaum, C. Lahuna, A. Dellal, N. Belfeki, J. Capron, E. Januel, B. Stankoff, S. Alamowitch, O. Fain
CER13789
2020,38,4,Suppl.126
Pg. 0110-0115
Free to view
Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry
S. Melchor, C. Sánchez-Piedra, M. Fernández Castro, J.L. Andreu, V. Martínez Taboada, A. Olivé, J. Rosas, R. Menor, Á. García-Aparicio, F.J. López Longo, S. Manrique-Arija, J.A. García Vadillo, R. López González, J. Narváez, C. Galisteo, J. González Martín, A. Naranjo, Ó. Illera, B. Moreira, E. Raya, M. Rodríguez López, E. Júdez, C. Moriano, V. Torrente-Segarra, B. García Magallón, C. Guillén Astete, I. Castellvi, C. Bohórquez, J. Loricera, J. Belzunegui, P.E. Carreira
on behalf of the Sjögrenser group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER)
S. Melchor, C. Sánchez-Piedra, M. Fernández Castro, J.L. Andreu, V. Martínez Taboada, A. Olivé, J. Rosas, R. Menor, Á. García-Aparicio, F.J. López Longo, S. Manrique-Arija, J.A. García Vadillo, R. López González, J. Narváez, C. Galisteo, J. González Martín, A. Naranjo, Ó. Illera, B. Moreira, E. Raya, M. Rodríguez López, E. Júdez, C. Moriano, V. Torrente-Segarra, B. García Magallón, C. Guillén Astete, I. Castellvi, C. Bohórquez, J. Loricera, J. Belzunegui, P.E. Carreira
on behalf of the Sjögrenser group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER)
CER13903
2020,38,4,Suppl.126
Pg. 0116-0124
Free to view
Clinically significant renal involvement in primary Sjögren's syndrome is associated with important morbidity: data from the Spanish Sjögrenser cohort
J. Narvaez, C. Sánchez-Piedra, M. Fernández-Castro, V. Martínez-Taboada, A. Olivé, J. Rosas, J.A. García-Vadillo, E. Júdez, E. Ruiz-Lucea, L. Romani, N. Montalá, J.L. Andreu
on behalf of the Sjögrenser Study Group
J. Narvaez, C. Sánchez-Piedra, M. Fernández-Castro, V. Martínez-Taboada, A. Olivé, J. Rosas, J.A. García-Vadillo, E. Júdez, E. Ruiz-Lucea, L. Romani, N. Montalá, J.L. Andreu
on behalf of the Sjögrenser Study Group
CER13880
2020,38,4,Suppl.126
Pg. 0125-0129
Free to view
T cell lymphoma in the setting of Sjögren’s syndrome: T cells gone bad? Report of five cases from a single centre cohort
I.E. Stergiou, A. Papageorgiou, L.G. Chatzis, A.G. Tzioufas, M. Voulgarelis, A. Goules
I.E. Stergiou, A. Papageorgiou, L.G. Chatzis, A.G. Tzioufas, M. Voulgarelis, A. Goules
Diagnosis
CER12659
2020,38,4,Suppl.126
Pg. 0130-0133
Free to view
Performance of the 2016 ACR/EULAR SS classification criteria in patients with secondary Sjögren’s syndrome
G. Hernández-Molina, C. Ávila-Casado, C. Hernández-Hernández, C. Recillas-Gispert, J. Sánchez-Guerrero
G. Hernández-Molina, C. Ávila-Casado, C. Hernández-Hernández, C. Recillas-Gispert, J. Sánchez-Guerrero
CER12844
2020,38,4,Suppl.126
Pg. 0134-0141
Free to view
Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations
E. Zampeli, M. Mavrommati, H.M. Moutsopoulos, F.N. Skopouli
E. Zampeli, M. Mavrommati, H.M. Moutsopoulos, F.N. Skopouli
CER13520
2020,38,4,Suppl.126
Pg. 0142-0149
Free to view
Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sjögren’s syndrome
J. Chen, Y. Jin, C. Li, Y. Gan, J. Li, S. Chen, X. Sun, J. He, Z. Li
J. Chen, Y. Jin, C. Li, Y. Gan, J. Li, S. Chen, X. Sun, J. He, Z. Li
CER13590
2020,38,4,Suppl.126
Pg. 0150-0157
Free to view
Nailfold capillaroscopy in Sjögren’s syndrome: a systematic literature review and standardised interpretation
K. Melsens, M.C. Leone, S. Paolino, D. Elewaut, R. Gerli, A. Vanhaecke, I. Peene, M. Cutolo, V. Smith
K. Melsens, M.C. Leone, S. Paolino, D. Elewaut, R. Gerli, A. Vanhaecke, I. Peene, M. Cutolo, V. Smith
CER13416
2020,38,4,Suppl.126
Pg. 0158-0165
Free to view
Positive histopathologic assessment in salivary glands shows little impact on clinical features of established primary Sjögren’s syndrome in a Korean population
Y. Park, J. Lee, J.H. Koh, J.Y. Choe, Y. Sung, S. Lee, S. Shim, J. Kim, S.R. Kwon, S.-H. Park, S. Kwok
Y. Park, J. Lee, J.H. Koh, J.Y. Choe, Y. Sung, S. Lee, S. Shim, J. Kim, S.R. Kwon, S.-H. Park, S. Kwok
CER13749
2020,38,4,Suppl.126
Pg. 0166-0173
Free to view
Characterisation of articular manifestations in primary Sjögren’s syndrome: clinical and imaging features
F. Carubbi, A. Alunno, A. Conforti, I. Riccucci, I. Di Cola, E. Bartoloni, R. Gerli
F. Carubbi, A. Alunno, A. Conforti, I. Riccucci, I. Di Cola, E. Bartoloni, R. Gerli
CER13779
2020,38,4,Suppl.126
Pg. 0174-0179
Free to view
A Training Tool to support the management and diagnosis of Sjögren’s syndrome
C. Chatzaki, A. Goules, S. De Vita, A. Zabotti, C. Delporte, M.S. Soyfoo, F. Barone, B.A. Fisher, P. Brito-Zerón, E. Bartoloni, C.P. Mavragani, D.I. Fotiadis, A.G. Tzioufas, M. Tsiknakis
C. Chatzaki, A. Goules, S. De Vita, A. Zabotti, C. Delporte, M.S. Soyfoo, F. Barone, B.A. Fisher, P. Brito-Zerón, E. Bartoloni, C.P. Mavragani, D.I. Fotiadis, A.G. Tzioufas, M. Tsiknakis
CER13774
2020,38,4,Suppl.126
Pg. 0180-0188
Free to view
The use of digital image analysis in the histological assessment of Sjögren’s syndrome salivary glands improves inter-rater agreement and facilitates multicentre data harmonisation
D. Lucchesi, E. Pontarini, V. Donati, M. Mandarano, A. Sidoni, E. Bartoloni, C. Baldini, A.R. Tappuni, M. Bombardieri
D. Lucchesi, E. Pontarini, V. Donati, M. Mandarano, A. Sidoni, E. Bartoloni, C. Baldini, A.R. Tappuni, M. Bombardieri
CER13961
2020,38,4,Suppl.126
Pg. 0189-0194
Free to view
Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren’s syndrome and related lymphoproliferation: results in independent cohorts
S. Gandolfo, C. Fabro, E. Kapsogeorgou, S. Colafrancesco, F. Ferro, E. Bartoloni, L. Quartuccio, A. Goules, R. Priori, A. Alunno, F. Conti, G. Valesini, R. Giacomelli, C. Baldini, R. Gerli, A.G. Tzioufas, S. De Vita
S. Gandolfo, C. Fabro, E. Kapsogeorgou, S. Colafrancesco, F. Ferro, E. Bartoloni, L. Quartuccio, A. Goules, R. Priori, A. Alunno, F. Conti, G. Valesini, R. Giacomelli, C. Baldini, R. Gerli, A.G. Tzioufas, S. De Vita
CER14018
2020,38,4,Suppl.126
Pg. 0195-0202
Free to view
Total area of inflammatory infiltrate and percentage of inflammatory infiltrate identify different clinical-serological subsets of primary Sjögren’s syndrome better than traditional histopathological parameters
V. Donati, F. Ferro, G. Governato, G. Fulvio, R. Izzetti, V. Nardini, C. Baldini
V. Donati, F. Ferro, G. Governato, G. Fulvio, R. Izzetti, V. Nardini, C. Baldini
CER13762
2020,38,4,Suppl.126
Pg. 0203-0209
Free to view
Ultrasound assessment of lacrimal glands: a cross-sectional study in healthy subjects and a preliminary study in primary Sjögren's syndrome patients
O. De Lucia, S. Zandonella Callegher, M.V. De Souza, N. Battafarano, N. Del Papa, M. Gerosa, I. Giovannini, A. Tullio, F. Valent, A. Zabotti, R. Caporali, S. De Vita
O. De Lucia, S. Zandonella Callegher, M.V. De Souza, N. Battafarano, N. Del Papa, M. Gerosa, I. Giovannini, A. Tullio, F. Valent, A. Zabotti, R. Caporali, S. De Vita
CER14017
2020,38,4,Suppl.126
Pg. 0210-0215
Free to view
Ultra-high frequency ultrasonography of labial glands is a highly sensitive tool for the diagnosis of Sjögren’s syndrome: a preliminary study
F. Ferro, R. Izzetti, S. Vitali, G. Aringhieri, S. Fonzetti, V. Donati, V. Dini, M. Mosca, M. Gabriele, D. Caramella, C. Baldini
F. Ferro, R. Izzetti, S. Vitali, G. Aringhieri, S. Fonzetti, V. Donati, V. Dini, M. Mosca, M. Gabriele, D. Caramella, C. Baldini
Treatment
CER13627
2020,38,4,Suppl.126
Pg. 0216-0221
Free to view
Mediterranean diet and risk of Sjögren’s syndrome
A. Machowicz, I. Hall, P. De Pablo, S. Rauz, A. Richards, J. Higham, A. Poveda-Gallego, F. Imamura, S.J. Bowman, F. Barone, B.A. Fisher
A. Machowicz, I. Hall, P. De Pablo, S. Rauz, A. Richards, J. Higham, A. Poveda-Gallego, F. Imamura, S.J. Bowman, F. Barone, B.A. Fisher
CER13885
2020,38,4,Suppl.126
Pg. 0222-0227
Free to view
Blocking T cell co-stimulation in primary Sjögren’s syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers
E. Pontarini, G.M. Verstappen, S. Grigoriadou, F.G. Kroese, H. Bootsma, M. Bombardieri
E. Pontarini, G.M. Verstappen, S. Grigoriadou, F.G. Kroese, H. Bootsma, M. Bombardieri
CER14041
2020,38,4,Suppl.126
Pg. 0228-0236
Free to view
Ianalumab (VAY736) in primary Sjögren’s syndrome: assessing disease activity using multi-modal ultrasound
T. Diekhoff, T. Fischer, Q. Schefer, M.G. Posch, T. Dörner, D. Laurent, Y. Li, F.D. Wagner, S.J. Oliver
T. Diekhoff, T. Fischer, Q. Schefer, M.G. Posch, T. Dörner, D. Laurent, Y. Li, F.D. Wagner, S.J. Oliver
Reviews
CER13380
2020,38,4,Suppl.126
Pg. 0237-0244
Free to view
What about glucocorticoids in primary Sjögren’s syndrome?
R. Priori, L. Mastromanno, R. Izzo
R. Priori, L. Mastromanno, R. Izzo
CER13536
2020,38,4,Suppl.126
Pg. 0245-0252
Free to view
Type-III interferons in Sjögren’s syndrome
E. Apostolou, A.G. Tzioufas
E. Apostolou, A.G. Tzioufas
CER13755
2020,38,4,Suppl.126
Pg. 0253-0260
Free to view
Checkpoint inhibition-induced sicca: a type II interferonopathy?
S. Pringle, X. Wang, A. Vissink, H. Bootsma, F.G. Kroese
S. Pringle, X. Wang, A. Vissink, H. Bootsma, F.G. Kroese
CER13786
2020,38,4,Suppl.126
Pg. 0261-0270
Free to view
Novel approaches for rescuing function of the salivary gland epithelium in primary Sjögren’s syndrome
X. Wang, H. Bootsma, J. De Koning, F.G. Kroese, S. Pringle
X. Wang, H. Bootsma, J. De Koning, F.G. Kroese, S. Pringle
CER13769
2020,38,4,Suppl.126
Pg. 0271-0282
Free to view
When B cells break bad: development of pathogenic B cells in Sjögren’s syndrome
J.H. Reed, G.M. Verstappen, M. Rischmueller, V.L. Bryant
J.H. Reed, G.M. Verstappen, M. Rischmueller, V.L. Bryant
CER13757
2020,38,4,Suppl.126
Pg. 0283-0290
Free to view
Ten years of the ESSDAI: is it fit for purpose?
L. De Wolff, S. Arends, J.F. Van Nimwegen, H. Bootsma
L. De Wolff, S. Arends, J.F. Van Nimwegen, H. Bootsma
CER13797
2020,38,4,Suppl.126
Pg. 0291-0300
Free to view
Interstitial lung disease in Sjögren’s syndrome: a clinical review
F. Luppi, M. Sebastiani, M. Silva, N. Sverzellati, A. Cavazza, C. Salvarani, A. Manfredi
F. Luppi, M. Sebastiani, M. Silva, N. Sverzellati, A. Cavazza, C. Salvarani, A. Manfredi
CER13821
2020,38,4,Suppl.126
Pg. 0301-0309
Free to view
Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sjögren’s syndrome
J. Vehof, T.P. Utheim, H. Bootsma, C.J. Hammond
J. Vehof, T.P. Utheim, H. Bootsma, C.J. Hammond
CER13792
2020,38,4,Suppl.126
Pg. 0310-0314
Free to view
Recent insights in the potential role of imaging modalities for diagnosing patients with primary Sjögren’s syndrome
E. Mossel, S. Arends, H. Bootsma
E. Mossel, S. Arends, H. Bootsma
CER13731
2020,38,4,Suppl.126
Pg. 0315-0323
Free to view
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes
S. Fasano, D. Mauro, F. Macaluso, F. Xiao, Y. Zhao, L. Lu, G. Guggino, F. Ciccia
S. Fasano, D. Mauro, F. Macaluso, F. Xiao, Y. Zhao, L. Lu, G. Guggino, F. Ciccia
Letters to the Editor
CER12899
2020,38,4,Suppl.126
Pg. 0324-0325
Free to view
Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjögren’s syndrome
L. La Barbera, G. Grasso, C. Rizzo, F. Ciccia, G. Guggino
L. La Barbera, G. Grasso, C. Rizzo, F. Ciccia, G. Guggino
CER13295
2020,38,4,Suppl.126
Pg. 0326
Free to view
Anti-dense fine speckled 70 antibodies in primary Sjögren’s syndrome
E. Conticini, J. Sota, P. Falsetti, F. Bellisai, M.R. Bacarelli, S.G. Al-Khayyat, L. Cantarini, B. Frediani
E. Conticini, J. Sota, P. Falsetti, F. Bellisai, M.R. Bacarelli, S.G. Al-Khayyat, L. Cantarini, B. Frediani